The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[[(5S)-3-[4-[4-[(E)-(2-chloro-6-nitro-phenyl)methyleneamino]piperazin-1-yl]-3-fluoro-phenyl]-2-oxo-oxazolidin-5-yl]methyl]acetamide ID: ALA5280238
Chembl Id: CHEMBL5280238
Max Phase: Preclinical
Molecular Formula: C23H24ClFN6O5
Molecular Weight: 518.93
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)NC[C@H]1CN(c2ccc(N3CCN(/N=C/c4c(Cl)cccc4[N+](=O)[O-])CC3)c(F)c2)C(=O)O1
Standard InChI: InChI=1S/C23H24ClFN6O5/c1-15(32)26-12-17-14-30(23(33)36-17)16-5-6-22(20(25)11-16)28-7-9-29(10-8-28)27-13-18-19(24)3-2-4-21(18)31(34)35/h2-6,11,13,17H,7-10,12,14H2,1H3,(H,26,32)/b27-13+/t17-/m0/s1
Standard InChI Key: PABUYRTWVAOUSZ-BMAFUFKNSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 518.93Molecular Weight (Monoisotopic): 518.1481AlogP: 3.00#Rotatable Bonds: 7Polar Surface Area: 120.62Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: CX Basic pKa: 1.31CX LogP: 2.62CX LogD: 2.62Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.34Np Likeness Score: -1.82
References 1. Zhao Q, Xin L, Liu Y, Liang C, Li J, Jian Y, Li H, Shi Z, Liu H, Cao W.. (2021) Current Landscape and Future Perspective of Oxazolidinone Scaffolds Containing Antibacterial Drugs., 64 (15.0): [PMID:34260235 ] [10.1021/acs.jmedchem.1c00480 ]